Publications

cemka > Publications

Classer les publications sur l'année

  • Économie de la santĂ©

    Cost-effectiveness of atorvastatin in the prevention of cardiovascular events in diabetic patients : A French adaptation of CARDS

    LAFUMA A, COLIN X, SOLESSE A

    Arch Cardiovasc Dis ; 2008;101(5):327-332

  • Économie de la santĂ©

    Cost-effectiveness analysis of vaccination against rotavirus with RIX4414 in France

    STANDAERT B, PAREZ N, TEHARD B, COLIN X, DETOURNAY B

    Appl Health Econ Health Policy ; 6(4):199-216

  • Économie de la santĂ©

    Aspects Ă©pidĂ©miologiques et Ă©conomiques de l’insulinothĂ©rapie en Fance mĂ©tropolitaine

    DETOURNAY B

    Med Mal Metab ; (2):149-152

  • Pharmaco-EpidĂ©miologie

    A european survey of patient satisfaction with spectacles after cataract surgery and the associated costs in four European countries (France, Germany, Spain and Italy)

    CUQ C, LAFUMA A, JEANBAT V, BERDEAUX G

    Ophthalmic Epidemiol ; 15:234-241

  • Pharmaco-EpidĂ©miologie

    Vasodilators and Nootropics as Predictors of Dementia and Mortality in the PAQUID Cohort

    DARTIGUES JF, CARCAILLON L, HELMER C, LECHEVALLIER N, LAFUMA A, KHOSHNOOD B

    J Am Geriatr Soc ; 55:395-399

  • SantĂ© publique

    Un outil de suivi et d’auto-Ă©valuation du bon usage du mĂ©dicament en cancĂ©rologie : l’observatoire du mĂ©dicament d la FNCLCC

    LATOUR JF, GAMEROFF S, GENEVE J, FAGNANI F

    J Pharm Clin ; 26(3):151-157

  • Pharmaco-EpidĂ©miologie

    Self-reported visual impairment and mortality: a French nationwide perspective

    BERDEAUX G, BREZIN AP, FAGNANI F, LAFUMA A, MESBAH M

    Ophthalmic Epidemiol ; 14(2):80-87

  • SantĂ© publique

    Public health impact of neovascular age-related macular degeneration treatments extrapolated from visual acuity

    BANDELLO F, LAFUMA A, BERDEAUX G

    Invest Ophtalmol Vis Sci ; 48(1):86-103

  • SantĂ© publique

    Prise en charge du diabĂšte en France : des progrĂšs certains

    VARROUD-VIAL M, GUERCI B, ATTALI C, SIMON D, DETOURNAY B, HALIMI S, BOUEE S, BRAMI G, FAGOT-CAMPAGNA A, NACHIT-OUINEKH F, ESCHWEGE E, CHARBONNEL B, GRIMALDI A

    RĂ©seaux DiabĂšte ; (31):4-9

  • SantĂ© publique

    PrĂ©valence et coĂ»t du diabĂšte en France : oĂč en est-on?

    DETOURNAY B, BRAMI G, NACHIT-OUINEKH F, ESCHWEGE E

    MĂ©decine des Maladies MĂ©taboliques ; 1(2):1-4

  • Pharmaco-EpidĂ©miologie

    La mortalitĂ© observĂ©e Ă  trois ans dans l’enquĂȘte CAROLE

    JALLON P, DE ZELICOURT M, FAGNANI F, LAURENDEAU C, FAILLIOT M

    Epilepsies ; 2007;19(3):173-177

  • Pharmaco-EpidĂ©miologie

    Irritable bowel syndrome in France : quality of life, medical management, and costs : the Encoli Study

    BRUN-STRANG C, DAPOIGNY M, LAFUMA A, WAINSTEN JP, FAGNANI F

    Eur J Gastroenterol Hepatol ; 19(12):1097-1103

  • Pharmaco-EpidĂ©miologie

    Anogenital warts incidence, medical management and costs in women consulting gynaecologists in France

    MONSONEGO J, BREUGELMANS JG, BOUEE S, LAFUMA A, BENARD S, REMY V

    Gynécol Obstét Fertil ; 35:107-113

  • Économie de la santĂ©

    Evaluation économique du trastuzumab en traitement adjuvant du cancer du sein précoce surexprimant HER2

    FAGNANI F, COLIN X, ARVEUX P, COUDERT B, MISSET JL

    Bulletin du Cancer ; 94(7):711-720

  • Pharmaco-EpidĂ©miologie

    Epidemiology, impact, management and cost of Paget’s disease of bone in France

    SARAUX A, BRUN-STRANG C, MIMAUD V, VIGNERON AM, LAFUMA A

    Joint Bone Spine ; 74(1):90-95